Lung Cancer Research Award

Lung Cancer Research Award

Funder: Respiratory Health Association (RHA)

Status: Active annual award (awarded since 1998)

Geographic Scope: United States

Focus Areas:

Lung cancer research

Early-stage/pilot and feasibility studies

Innovative research on lung cancer mechanisms

Research on inflammation and lung injury

Tumor growth and immune response regulation

Potential therapeutic targets for lung cancer treatment

Award Purpose:
To encourage early-stage investigators interested in conducting innovative research studies in lung cancer. This award is meant to catalyze pilot and feasibility studies which generate preliminary data that can be used to compete for federally funded grants, ultimately leading to advancements in lung cancer treatment.

Award Amount: $100,000 (one-time award)

Eligibility:

Early-stage investigators/researchers

Those conducting innovative lung cancer research

Recent Recipients:

2024: Jing Liu, PhD - Award for research focused on understanding the mechanisms that regulate lung inflammation and injury, including targeting the gene regulator Miz-1

Background:
Lung cancer is the fourth leading cause of death in the U.S. and has historically been underfunded for research despite its impact.

Contact Information:

Phone: 1-888-880-LUNG(5864)

Email: info@RespHealth.org

Address: 1440 W. Washington Blvd. Chicago, IL 60607

Website: resphealth.org/Research